Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana

British Medical Journal

Volumn 331, Issue 7519, 2005, Pages 727-733

  Chandramohan, Daniel ^a   Owusu Agyei, Seth ^c   Carneiro, Ilona ^a   Awine, Timothy ^d   Amponsa Achiano, Kwame ^d   Mensah, Nathan ^d   Jaffar, Shabbar ^a   Baiden, Rita ^d   Hodgson, Abraham ^d   Binka, Fred ^e   Greenwood, Brian ^a,b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b Gates Malaria Partnership ^*

^c KINTAMPO HEALTH RESEARCH CENTRE   (Ghana)

^d NAVRONGO HEALTH RESEARCH CENTRE   (Ghana)

^e Studies of the Epidemiology of Epilepsy in Demographic Surveillance Systems   (Ghana)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; FANSIDAR; HERBACEOUS AGENT; PLACEBO;

ANEMIA; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DIARRHEA; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG SENSITIVITY; FOLLOW UP; GHANA; HOSPITAL ADMISSION; HUMAN; INCIDENCE; IRON THERAPY; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; MEASLES VACCINATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RISK ASSESSMENT; SEASONAL VARIATION; SEPTICEMIA; SIDE EFFECT; VOMITING;

EID: 26244448865     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.331.7519.727     Document Type: Article

References (20)

1. Snow R, Guerra C, Noor A, Myint H, Hay S. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005;434:214-7.
2. Murray CJ, Lopez AD. Global burden of disease and injury series. Geneva: World Health Organization, 1996:320-7.
3. Murphy SC, Breman JG. Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anaemia, respiratory distress, hypoglycaemia and complications of pregnancy. Am J Trop Med Hyg 2001;64(1-2suppl):57-67.
4. Schellenberg D, Menendez C, Kahigwa E, Font F, Galindom C, Acosta C, et al. African children with malaria in an area of intense Plasmodium falciparum transmission: features on admission to the hospital and risk factors for death. Am J Trop Med Hyg 1999;61:431-8.
5. Schellenberg D, Schellenberg JR, Mushi A, Savigny D, Mgalula L, Mbuya C, et al. The silent burden of anaemia in Tanzanian children: a community-based study. Bull World Health Organ 2003;81:581-90.
6. Kitua AY, Smith TA, Alonso PL, Urassa H, Masanja H, Kimario J, et al. The role of low level Plasmodium falciparum parasitaemia in anaemia among infants living in an area of intense and perennial transmission. Trop Med Int Health 1997;2:325-33.
7. Menendez C, Kahigwa E, Hirt R, Vounatsou P, Aponte JJ, Font F, et al. Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants. Lancet 1997;350:844-50.
8. Schellenberg D, Menendez C, Kahigwa E, Aponte J, Vidal J, Tanner M, et al. Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial. Lancet 2001;357:1471-7.
9. Massaga JJ, Kitua AY, Lemnge MM, Akida JA, Malle LN, Ronn AM, et al. Effect of intermittent treatment with amodiaquine on anaemia and malarial fevers in infants in Tanzania: a randomised placebo-controlled trial. Lancet 2003;361:1853-60.
10. Appawu M, Owusu-Agyei S, Dadzie S, Asoala V, Anto F, Koram K, et al. Malaria transmission dynamics at a site in northern Ghana proposed for testing malaria vaccines. Trop Med Int Health 2004;9:164-70.
11. Oduro AR, Anyorigiya T, Hodgson A, Ansah P, Anto F, Ansah NA, et al. A randomized comparative study of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Ghana. Trop Med Int Health 2005;10:279-84.
12. Population, Health and Survival at Indepth sites. Ottawa, Canada: International Development Research Centre, 2002.
13. Drakeley C, Schellenberg D, Kihonda J, Sousa CA, Arez AP, Lopes D, et al. An estimation of the entomological inoculation rate for Ifakara: a semi-urban area in a region of intense malaria transmission in Tanzania. Trop Med Int Health 2003;8:767-74.
14. Cisse B, Sokhna CS, Alexander N, Trape JF, Greenwood B. A double blind, randomised placebo-controlled trial to measure the potential of SIPT with artesunate pus SP to reduce the malaria burden in Niakhar, Senegal. Am J Trop Med Hyg 2004;71(suppl):abstract 17.
15. Dicko A, Sagara I, Sissoko M, Guindo O, Diallo A, Kone M, et al. Impact of intermittent preventive treatment with sulphadoxine-pyrimethamine targeting the transmission season on the incidence of clinical malaria in children of 6 months to 10 years in Kambili, Mali. Am J Trop Med Hyg 2004;71(suppl):abstract 18.
16. Schellenberg D, Menendez C, Aponte J, Kahigwa E, Tanner M, Mshinda H, et al. Intermittent treatment antimalarial treatment for Tanzanian infants: follow-up to age 2 years of a randomised, placebo-controlled trial. Lancet 2005;365:1481-3.
17. Lengeler C. Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database Syst Rev 2004;(2):CD000363.
18. Greenwood BM, Greenwood AM, Bradley AK, Snow RW, Byass P, Hayes RJ, et al. Comparison of two strategies for control of malaria within a primary health care programme in the Gambia. Lancet 1988;i:1121-7.
19. Grabowsky M, Nobiya T, Ahun M, Donna R, Lengor M, Zimmerman D, et al. Distributing insecticide-treated bednets during measles vaccination: a low-cost means of achieving high and equitable coverage. Bull World Health Organ 2005;83:195-201.
20. Snow RW, Marsh K. The consequences of reducing transmission of Plasmodium falciparum in Africa. Adv Parasitol 2002;52:235-64.